Alpha beta counters

SB-216 is a potent tubulin polymerization inhibitor. SB-216 shows strong antiproliferative potency in a panel of human cancer cell lines, including melanoma, lung cancer , and breast cancer .  SB-216 can be used for cancer

SB-216 is a potent tubulin polymerization inhibitor. SB-216 shows strong antiproliferative potency in a panel of human cancer cell lines, including melanoma, lung cancer , and breast cancer .  SB-216 can be used for cancer

SB-216 is a potent tubulin polymerization inhibitor. SB-216 shows strong antiproliferative potency in a panel of human cancer cell lines, including melanoma, lung cancer , and breast cancer .  SB-216 can be used for cancer

SB-216 is a potent tubulin polymerization inhibitor. SB-216 shows strong antiproliferative potency in a panel of human cancer cell lines, including melanoma, lung cancer , and breast cancer .  SB-216 can be used for cancer

SB-410220.

SB-410220.

RO27-3225 TFA is potent and selective melanocortin 4 receptor (MC4R) agonist with an EC 50 of 1 nM and 8 nM for MC4R and MC1R , respectively. RO27-3225 TFA shows ~30-fold selectivity for MC4R over MC3R . RO27-3225 TFA has neuroprotective and

RO27-3225 TFA is potent and selective melanocortin 4 receptor (MC4R) agonist with an EC 50 of 1 nM and 8 nM for MC4R and MC1R , respectively. RO27-3225 TFA shows ~30-fold selectivity for MC4R over MC3R . RO27-3225 TFA has neuroprotective and

RO27-3225 TFA is potent and selective melanocortin 4 receptor (MC4R) agonist with an EC 50 of 1 nM and 8 nM for MC4R and MC1R , respectively. RO27-3225 TFA shows ~30-fold selectivity for MC4R over MC3R . RO27-3225 TFA has neuroprotective and

RO27-3225 TFA is potent and selective melanocortin 4 receptor (MC4R) agonist with an EC 50 of 1 nM and 8 nM for MC4R and MC1R , respectively. RO27-3225 TFA shows ~30-fold selectivity for MC4R over MC3R . RO27-3225 TFA has neuroprotective and

RO-28-1675 is a potent allosteric glucokinase (GK) activator with an EC 50 of 54 nM. RO-28-1675 can be used for the research of type 2 diabetesIn VitroRO-28-1675 can reverse the inhibitory action of the human glucokinase regulatory protein (GKRP).

RO-28-1675 is a potent allosteric glucokinase (GK) activator with an EC 50 of 54 nM. RO-28-1675 can be used for the research of type 2 diabetesIn VitroRO-28-1675 can reverse the inhibitory action of the human glucokinase regulatory protein (GKRP).